A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

NCT05886491 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision (No safety concern)

Conditions

Interventions

Sponsor

Takeda